IN8BIO Inc. Announces 1-for-30 Reverse Stock Split Effective June 5, 2025
IN8bio, Inc. announced a reverse stock split at a 1-for-30 ratio, effective June 5, 2025. As a result, every 30 shares of common stock will be consolidated into one share, with no change in the par value. Following this adjustment, approximately 3,444,234 shares will be outstanding. The company's stock will trade on a split-adjusted basis on Nasdaq starting June 6, 2025, under the new CUSIP number 45674E208. Fractional shares will not be issued, and cash payments will be made in lieu of them.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-134487), on June 04, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。